Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Unfortunately the same exact thing was siad for 2017. And same exact thing was also said for 2016 (especially after best ever GOG data was released in late 2015). Now its 2018. And 12 months from now 2019 will be the make or break year. The data with keytruda will still be early stage data. The strongest data that can be released is late stage or final phase 3 data. Anything before that is just interim data that might or might not move the stock or shock the market. ADXS needs to release final data, that is good, with a plan to market. If that were to occur nothing would be able to stop this thing. This data is expected 2020 I beleive.

Keep in mind you are not allowing for any delays in your 12 month window. Risky given the history of ADXS. FYI A 6 month delay puts you in mid 2019 which is not that far from 2020.